WallStreetZenWallStreetZen

NASDAQ: CLYM
Climb Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Climb Bio earnings were -$52.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CLYM earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$13.7M, down 21.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CLYM reported annual earnings of -$59.9M, with -19% growth.

CLYM earnings history

Current Revenue
$0.0
Current Earnings
-$52.8M
Current Profit Margin
0%

CLYM Return on Equity

Current Company
-31.5%
Current Industry
-145.3%
Current Market
5.2%
CLYM's Return on Equity (-31.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CLYM Return on Assets

Current Company
-30.4%
Current Industry
-9.7%
CLYM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CLYM announces earnings.

CLYM Return on Capital Employed

Current Company
-35.6%
Current Industry
-5.8%
CLYM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLYM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CLYM-$52.44M-$52.79MN/A-$0.77
ZVRA$144.61M$124.22MN/A$2.05
BBOT-$133.43M-$134.04MN/A-$4.30
CADL-$34.90M-$38.18MN/A-$0.72
KYTX-$156.12M-$161.31MN/A-$3.64
View Top Biotech Stocks

Climb Bio Earnings Reports & History FAQ

What were Climb Bio's earnings last quarter?

Climb Bio (NASDAQ: CLYM) reported Q1 2026 earnings per share (EPS) of -$0.20, up 35.48% year over year. Total CLYM earnings for the quarter were -$13.72 million. In the same quarter last year, Climb Bio's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Climb Bio stock.

Is Climb Bio profitable or losing money?

As of the last Climb Bio earnings report, Climb Bio is currently losing money. Climb Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$52.79 million, a 43.22% decrease year over year.

What was CLYM's earnings growth in the past year?

As of Climb Bio's earnings date in Q2 2026, Climb Bio's earnings has grown year over year. CLYM earnings in the past year totalled -$52.79 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.